Table 3. Results in previous reports... | American Society of Hematology

Table 3.

Results in previous reports using fully myeloablative regimens in allogeneic hematopoietic stem-cell transplantation in myelofibrosis, and in the current one with RIC regimens

Reference	No. of patients	Median age, y	Intermediate/high risk, Dupriez, %	Regimen	TRM, %	CR, %	OS, %
Guardiola et al^13,17	55	42	76	Myeloablative	27	40	14 (> 45 y) at 5 y
							62 (< 45 y) at 5 y
Daly et al¹⁴	25	48	84	Myeloablative	48	33	41 at 2.9 y
Deeg et al¹⁵	56	43	54	Myeloablative	32	53	64 at 2.8 y
Current study	21	54	100	RIC	10	76	86 at 2.7 y

Reference	No. of patients	Median age, y	Intermediate/high risk, Dupriez, %	Regimen	TRM, %	CR, %	OS, %
Guardiola et al^13,17	55	42	76	Myeloablative	27	40	14 (> 45 y) at 5 y
							62 (< 45 y) at 5 y
Daly et al¹⁴	25	48	84	Myeloablative	48	33	41 at 2.9 y
Deeg et al¹⁵	56	43	54	Myeloablative	32	53	64 at 2.8 y
Current study	21	54	100	RIC	10	76	86 at 2.7 y

CR indicates complete remission.

^*Median follow-up.

View Large

This Feature Is Available To Subscribers Only